Abstract
Profound changes in microRNA (miR) expression levels are frequently found in liver cancers compared to the normal liver. In this study, we evaluate the expression of miR-224 in human HCC and CCA, as well as its downstream targets and affected pathways. We show that miR-224 is upregulated in a large cohort of human CCA, similar to its upregulation in human HCC. For the purpose of studying the roles of miR-224 in HCC and CCA, we enforced miR-224 expression in cells. mRNA arrays followed by Ingenuity Pathway Analysis (IPA)-identified putative molecules and pathways downstream of miR-224. Phenotypically, we report that enforced expression of miR-224 increases the growth rate of normal cholangiocytes, CCA cell lines, and HCC cell lines. In addition, we identified, in an unbiased fashion, that one of the major biologic processes affected by miR-224 is Gap1 (G1) to Synthesis (S) transition checkpoint release. We next identified p21, p15, and CCNE1 as downstream targets of miR-224 and confirmed the coordinated downregulation results in the increased phosphorylation of Retinoblastoma (Rb) with resulting G1/S checkpoint release. Our data suggest that miR-224 is a master regulator of cell cycle progression, and that its overexpression res...Continue Reading
References
Apr 21, 2001·Gene Therapy·A WahlersC Baum
Jan 18, 2005·Cell·Benjamin P LewisDavid P Bartel
Mar 1, 2006·Proceedings of the National Academy of Sciences of the United States of America·Jordan M CumminsVictor E Velculescu
May 20, 2006·Blood·Gabriel GhiaurDavid A Williams
Jun 10, 2006·Gastroenterology·Fanyin MengTushar Patel
Jan 24, 2007·Molecular and Cellular Biology·Peter S LinsleyLee Lim
Apr 4, 2007·Oncogene·J L MottG J Gores
Aug 8, 2007·Gastroenterology·Fanyin MengTushar Patel
Dec 26, 2007·Methods : a Companion to Methods in Enzymology·Yuriy Gusev
Mar 6, 2008·The Journal of Biological Chemistry·Yu WangCaroline G L Lee
Apr 25, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yannick LadeiroJessica Zucman-Rossi
Jun 16, 2009·Cell·Janaiah KotaJoshua T Mendell
Oct 2, 2009·Journal of Gastroenterology and Hepatology·Qiong LiDong Wang
Dec 19, 2009·Proceedings of the National Academy of Sciences of the United States of America·Pascal PineauAnne Dejean
Feb 11, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chiara BraconiTushar Patel
Aug 13, 2010·Nature·Huili GuoDavid P Bartel
Dec 15, 2010·Journal of Hepatology·Peng GaoIrene Oi-Lin Ng
Jan 20, 2011·Nature Reviews. Genetics·Eric Huntzinger, Elisa Izaurralde
Apr 5, 2011·Nature Reviews. Gastroenterology & Hepatology·Tushar Patel
Aug 27, 2011·Methods in Molecular Biology·Stuart MaudsleySung-Soo Park
Sep 29, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Nataliya RazumilavaJustin L Mott
Nov 16, 2011·Seminars in Oncology·Chiara BraconiTushar Patel
Nov 30, 2011·Epigenomics·Yu Wang, Caroline G L Lee
Nov 14, 2013·Journal of Gastroenterology and Hepatology·Qiong LiGe Wang
Jun 13, 2014·British Journal of Cancer·H WangR Wang
Citations
Sep 15, 2016·PloS One·YongJie HuangXiaodong Cheng
Jun 18, 2019·Journal of Cellular and Molecular Medicine·Yaoyong LuGong Zhang
Aug 3, 2019·Molecular Carcinogenesis·Merricka C LivingstoneJohn D Groopman
Feb 26, 2020·Physiological Reports·John C RasmussenEva M Sevick-Muraca
Dec 31, 2016·Oncotarget·Jian'an BaiQiyun Tang
Jul 28, 2016·Oncotarget·Wataru OkajimaEigo Otsuji
Sep 15, 2018·Oncology Letters·Xiaoxiao LiuZhiming Wu
Dec 20, 2018·Oncogenesis·Wei WangYunping Luo
Nov 2, 2018·Viruses·Marie-Laure PlissonnierMirjam B Zeisel
Mar 20, 2019·Disease Markers·Li ZhangShixing Qiao
Dec 3, 2020·Annual Review of Pathology·Pedro M RodriguesJesus M Banales
Nov 7, 2020·Biomarkers in Medicine·Lichao YangMin He
Jun 1, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Khadijeh MahboobniaAmirhossein Sahebkar